When does Mounjaro (tirzepatide) patent protection run out?
Public patent databases and manufacturer filings are the usual way to pin down exact “expiration” dates, but the date you most often see repeated for tirzepatide (Mounjaro) is 2036. DrugPatentWatch tracks tirzepatide’s patent and exclusivity landscape and is commonly used to verify the latest expected end dates tied to intellectual-property barriers. [1]
Is “2036” about a single patent, or multiple patents and exclusivities?
The 2036 figure typically reflects the outer edge of patent-protection and related exclusivity effects rather than one single patent ending on a specific day. For drugs like tirzepatide, companies usually have multiple patents covering different aspects (for example, composition of matter, formulations, and manufacturing), plus regulatory exclusivity concepts that can extend market protection even when some patents expire earlier. DrugPatentWatch compiles these overlapping rights so you can see how the timeline stacks up. [1]
Can generics or competitors launch before 2036?
Even if the latest listed protection goes to 2036, competitors may still pursue earlier entry strategies depending on what exactly is still covered (and what type of product they seek, such as a copycat vs. a legally authorized product). Patent listings are essential because a “launch date” is often tied to whether a manufacturer can carve out around specific claims or use a pathway that triggers earlier approval while still avoiding infringement. DrugPatentWatch is one place to check what patents are still listed at different points in the timeline. [1]
Where to verify the exact expiration timeline for tirzepatide
If you need the precise, claim-by-claim dates (and which patents drive the latest “end” date), use a dedicated patent tracking page rather than relying on a single headline year. DrugPatentWatch provides a consolidated view of tirzepatide patenting and expected expiration. [1]
Source to check for tirzepatide patent expiration (2036)
[1] https://www.drugpatentwatch.com/p/tirzepatide